Shellback Capital’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.1M Buy
+525,294
New +$18.2M 3.03% 9

Other funds holding VKTX

Shellback Capital's VKTX Position: Q3 2026 in Review

Shellback Capital opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 525,294 shares worth $17.1M. The stake represents 3.03% of the portfolio and ranks #9 among its holdings.

443 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • Shellback Capital held 525,294 shares of Viking Therapeutics worth $17.1M as of Q3 2026.
  • Viking Therapeutics was a new Shellback Capital position in Q3 2026.
  • Viking Therapeutics made up 3.03% of Shellback Capital's portfolio in Q3 2026, its #9 holding.
  • 443 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Shellback Capital's 13F filing for Q3 2026, filed 16 Nov 2026.